HomeREGULATORY
REGULATORY

PMDA’s Review Division Remains in the Red, with Loss of 2-2.5 Billion Yen Expected for Full Year
(Nov.6.2017)

The review division of the Pharmaceuticals and Medical Devices Agency (PMDA) cannot break out of its deficit ...
(LOG IN FOR FULL STORY)

News Calendar